Changes in antioxidant enzyme activity and malondialdehyde level in patients with age-related macular degeneration

Ophthalmologica. 2004 May-Jun;218(3):202-6. doi: 10.1159/000076845.

Abstract

Age-related macular degeneration is the leading cause of legal blindness in the developed world, and yet its pathogenesis remains poorly understood. Oxidative stress may play a major role in the etiology and pathogenesis of age-related disorders such as age-related macular degeneration. Catalase is an antioxidant enzyme which plays an important role in the detoxification of free oxygen radicals. Malondialdehyde is a marker that shows free radical damage. We have measured the erythrocyte activity of catalase and the serum level of malondialdehyde in 30 patients with age-related macular degeneration and 60 healthy subjects. Patients with age-related macular degeneration showed significantly lower catalase activity compared to healthy subjects (p = 0.002). Plasma malondialdehyde level of the patient group was significantly higher than that of the controls (p = 0.038).

MeSH terms

  • Aged
  • Case-Control Studies
  • Catalase / blood*
  • Erythrocytes / enzymology
  • Female
  • Humans
  • Macular Degeneration / blood*
  • Male
  • Malondialdehyde / blood*
  • Middle Aged
  • Sex Characteristics

Substances

  • Malondialdehyde
  • Catalase